The effects of Bu Yang Huan Wu Tang on post-stroke epilepsy: a nationwide matched study

Shu-Wen Weng,1,* Ta-Liang Chen,2–4 Chun-Chieh Yeh,5,6 Hsin-Long Lane,7 Chien-Chang Liao,2–4,8,* Chun-Chuan Shih7,9 1Department of Chinese Medicine, Taichung Hospital, Ministry of Health and Welfare, Taichung, Taiwan; 2Department of Anesthesiology, Taipei Medical University Hospit...

Full description

Bibliographic Details
Main Authors: Weng SW, Chen TL, Yeh CC, Lane HL, Liao CC, Shih CC
Format: Article
Language:English
Published: Dove Medical Press 2018-12-01
Series:Clinical Epidemiology
Subjects:
Online Access:https://www.dovepress.com/the-effects-of-bu-yang-huan-wu-tang-on-post-stroke-epilepsy-a-nationwi-peer-reviewed-article-CLEP
_version_ 1818136823737614336
author Weng SW
Chen TL
Yeh CC
Lane HL
Liao CC
Shih CC
author_facet Weng SW
Chen TL
Yeh CC
Lane HL
Liao CC
Shih CC
author_sort Weng SW
collection DOAJ
description Shu-Wen Weng,1,* Ta-Liang Chen,2–4 Chun-Chieh Yeh,5,6 Hsin-Long Lane,7 Chien-Chang Liao,2–4,8,* Chun-Chuan Shih7,9 1Department of Chinese Medicine, Taichung Hospital, Ministry of Health and Welfare, Taichung, Taiwan; 2Department of Anesthesiology, Taipei Medical University Hospital, Taipei, Taiwan; 3Anesthesiology and Health Policy Research Center, Taipei Medical University Hospital, Taipei, Taiwan; 4Department of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; 5Department of Surgery, China Medical University Hospital, Taichung, Taiwan; 6Department of Surgery, University of Illinois, Chicago, IL, USA; 7School of Chinese Medicine for Post-Baccalaureate, I-Shou University, Kaohsiung, Taiwan; 8School of Chinese Medicine, China Medical University, Taichung, Taiwan; 9Program for the Clinical Drug Discovery from Botanical Herbs, Taipei Medical University, Taipei, Taiwan *These authors contributed equally to this work Objective: To compare the long-term risk of epilepsy in stroke patients who use Bu Yang Huan Wu Tang (BYHWT) and those who do not. Methods: In the Taiwanese national insurance claims data, we identified newly diagnosed stroke patients receiving inpatient care in the years 2000–2004. Using propensity score-matched pairs to balance the baseline characteristics, we selected eligible stroke patients who did (n=8,971) and did not (n=8,971) receive BYHWT. These two groups were followed up until the end of 2009 to track the occurrence of epilepsy. We used Cox proportional hazard models to calculate the adjusted HRs and 95% CIs for post-stroke epilepsy during the follow-up period according to BYHWT use. Results: Compared with the control group, stroke patients with BYHWT had a reduced risk of epilepsy during the 5–9 years of the follow-up period (HR 0.69, 95% CI 0.61–0.77). The association between BYHWT and reduced post-stroke epilepsy was significant in various subgroups of stroke patients. There was a dose-dependent decrease in the frequency of epilepsy with increasing quantities of BYHWT use from 1 package (HR 0.77, 95% CI 0.66–0.90) to ≥6 packages (HR 0.52, 95% CI 0.42–0.65). Conclusion: Stroke patients who received BYHWT therapy had a reduced long-term risk of epilepsy, and the beneficial effect could be observed in various subgroups. However, future clinical trials will be necessary to corroborate the present findings and identify the biochemical mechanism involved. Keywords: stroke, epilepsy, Bu Yang Huan Wu Tang, long-term risk
first_indexed 2024-12-11T09:46:32Z
format Article
id doaj.art-0e54aaf61373432ab30d4ac070d6dc04
institution Directory Open Access Journal
issn 1179-1349
language English
last_indexed 2024-12-11T09:46:32Z
publishDate 2018-12-01
publisher Dove Medical Press
record_format Article
series Clinical Epidemiology
spelling doaj.art-0e54aaf61373432ab30d4ac070d6dc042022-12-22T01:12:33ZengDove Medical PressClinical Epidemiology1179-13492018-12-01Volume 101839185042927The effects of Bu Yang Huan Wu Tang on post-stroke epilepsy: a nationwide matched studyWeng SWChen TLYeh CCLane HLLiao CCShih CCShu-Wen Weng,1,* Ta-Liang Chen,2–4 Chun-Chieh Yeh,5,6 Hsin-Long Lane,7 Chien-Chang Liao,2–4,8,* Chun-Chuan Shih7,9 1Department of Chinese Medicine, Taichung Hospital, Ministry of Health and Welfare, Taichung, Taiwan; 2Department of Anesthesiology, Taipei Medical University Hospital, Taipei, Taiwan; 3Anesthesiology and Health Policy Research Center, Taipei Medical University Hospital, Taipei, Taiwan; 4Department of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; 5Department of Surgery, China Medical University Hospital, Taichung, Taiwan; 6Department of Surgery, University of Illinois, Chicago, IL, USA; 7School of Chinese Medicine for Post-Baccalaureate, I-Shou University, Kaohsiung, Taiwan; 8School of Chinese Medicine, China Medical University, Taichung, Taiwan; 9Program for the Clinical Drug Discovery from Botanical Herbs, Taipei Medical University, Taipei, Taiwan *These authors contributed equally to this work Objective: To compare the long-term risk of epilepsy in stroke patients who use Bu Yang Huan Wu Tang (BYHWT) and those who do not. Methods: In the Taiwanese national insurance claims data, we identified newly diagnosed stroke patients receiving inpatient care in the years 2000–2004. Using propensity score-matched pairs to balance the baseline characteristics, we selected eligible stroke patients who did (n=8,971) and did not (n=8,971) receive BYHWT. These two groups were followed up until the end of 2009 to track the occurrence of epilepsy. We used Cox proportional hazard models to calculate the adjusted HRs and 95% CIs for post-stroke epilepsy during the follow-up period according to BYHWT use. Results: Compared with the control group, stroke patients with BYHWT had a reduced risk of epilepsy during the 5–9 years of the follow-up period (HR 0.69, 95% CI 0.61–0.77). The association between BYHWT and reduced post-stroke epilepsy was significant in various subgroups of stroke patients. There was a dose-dependent decrease in the frequency of epilepsy with increasing quantities of BYHWT use from 1 package (HR 0.77, 95% CI 0.66–0.90) to ≥6 packages (HR 0.52, 95% CI 0.42–0.65). Conclusion: Stroke patients who received BYHWT therapy had a reduced long-term risk of epilepsy, and the beneficial effect could be observed in various subgroups. However, future clinical trials will be necessary to corroborate the present findings and identify the biochemical mechanism involved. Keywords: stroke, epilepsy, Bu Yang Huan Wu Tang, long-term riskhttps://www.dovepress.com/the-effects-of-bu-yang-huan-wu-tang-on-post-stroke-epilepsy-a-nationwi-peer-reviewed-article-CLEPstrokeepilepsyBu Yang Huan Wu Tanglong-term risk
spellingShingle Weng SW
Chen TL
Yeh CC
Lane HL
Liao CC
Shih CC
The effects of Bu Yang Huan Wu Tang on post-stroke epilepsy: a nationwide matched study
Clinical Epidemiology
stroke
epilepsy
Bu Yang Huan Wu Tang
long-term risk
title The effects of Bu Yang Huan Wu Tang on post-stroke epilepsy: a nationwide matched study
title_full The effects of Bu Yang Huan Wu Tang on post-stroke epilepsy: a nationwide matched study
title_fullStr The effects of Bu Yang Huan Wu Tang on post-stroke epilepsy: a nationwide matched study
title_full_unstemmed The effects of Bu Yang Huan Wu Tang on post-stroke epilepsy: a nationwide matched study
title_short The effects of Bu Yang Huan Wu Tang on post-stroke epilepsy: a nationwide matched study
title_sort effects of bu yang huan wu tang on post stroke epilepsy a nationwide matched study
topic stroke
epilepsy
Bu Yang Huan Wu Tang
long-term risk
url https://www.dovepress.com/the-effects-of-bu-yang-huan-wu-tang-on-post-stroke-epilepsy-a-nationwi-peer-reviewed-article-CLEP
work_keys_str_mv AT wengsw theeffectsofbuyanghuanwutangonpoststrokeepilepsyanationwidematchedstudy
AT chentl theeffectsofbuyanghuanwutangonpoststrokeepilepsyanationwidematchedstudy
AT yehcc theeffectsofbuyanghuanwutangonpoststrokeepilepsyanationwidematchedstudy
AT lanehl theeffectsofbuyanghuanwutangonpoststrokeepilepsyanationwidematchedstudy
AT liaocc theeffectsofbuyanghuanwutangonpoststrokeepilepsyanationwidematchedstudy
AT shihcc theeffectsofbuyanghuanwutangonpoststrokeepilepsyanationwidematchedstudy
AT wengsw effectsofbuyanghuanwutangonpoststrokeepilepsyanationwidematchedstudy
AT chentl effectsofbuyanghuanwutangonpoststrokeepilepsyanationwidematchedstudy
AT yehcc effectsofbuyanghuanwutangonpoststrokeepilepsyanationwidematchedstudy
AT lanehl effectsofbuyanghuanwutangonpoststrokeepilepsyanationwidematchedstudy
AT liaocc effectsofbuyanghuanwutangonpoststrokeepilepsyanationwidematchedstudy
AT shihcc effectsofbuyanghuanwutangonpoststrokeepilepsyanationwidematchedstudy